Roxanne Macias

Roxanne Macias has held a number of roles in the medical industry since 2007. Roxanne began their career as Regional Sales Manager (Southwest) USA at Arteriocyte Medical Systems in 2007, before becoming Sales Director EMEA in the same company. In 2014 they moved to the Piramal Group as Business Unit Manager, and then to Anika Therapeutics as EU Market Development Manager in 2016. Most recently, they joined Graftys in 2021 as Chief Commercial Officer (CCO).

Roxanne Macias attended The University of Texas at San Antonio from 2000 to 2007, earning a degree in Biology/Business Administration with a focus in Pre-Medicine/Pre-Medical Studies. In 2020, they completed a course in Organizational Leadership/ Digital Health from HarvardX.